Changchun High & New Technology Industry (Group) Inc. is an investment holding company. Through its subsidiaries, the Company manufactures biopharmaceuticals and Chinese traditional medicines, constructs infrastructure facilities, manufactures electrolytic condensers, and develops and manages real estate.
China’s state media reported this week that Han Chunyu’s scientific results on genome editing which were published in Nature Biotechnology in May...